UA28288A - Method for treatment of schizophrenia - Google Patents

Method for treatment of schizophrenia

Info

Publication number
UA28288A
UA28288A UA96041604A UA96041604A UA28288A UA 28288 A UA28288 A UA 28288A UA 96041604 A UA96041604 A UA 96041604A UA 96041604 A UA96041604 A UA 96041604A UA 28288 A UA28288 A UA 28288A
Authority
UA
Ukraine
Prior art keywords
schizophrenia
galoperidol
medical treatment
treatment
introduction
Prior art date
Application number
UA96041604A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Петро Тодорович Петрюк
Петр Тодорович Петрюк
Original Assignee
Петро Тодорович Петрюк
Петр Тодорович Петрюк
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Петро Тодорович Петрюк, Петр Тодорович Петрюк filed Critical Петро Тодорович Петрюк
Priority to UA96041604A priority Critical patent/UA28288A/en
Publication of UA28288A publication Critical patent/UA28288A/en

Links

Abstract

The invention relates to the psychiatry and can be used for medical treatment of patients with paranoial schizophrenia. The method for medical treatment of schizophrenia includes application of galoperidol and central electroanalgesia. Additionally for 6 days against a background of oral introduction of galoperidol the medical treatment is carried out by the method of "rapid neyrodeptisating" frequent intramuscular introduction of galoperidol at day's doses from middle to high).
UA96041604A 1996-04-23 1996-04-23 Method for treatment of schizophrenia UA28288A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA96041604A UA28288A (en) 1996-04-23 1996-04-23 Method for treatment of schizophrenia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA96041604A UA28288A (en) 1996-04-23 1996-04-23 Method for treatment of schizophrenia

Publications (1)

Publication Number Publication Date
UA28288A true UA28288A (en) 2000-10-16

Family

ID=74396332

Family Applications (1)

Application Number Title Priority Date Filing Date
UA96041604A UA28288A (en) 1996-04-23 1996-04-23 Method for treatment of schizophrenia

Country Status (1)

Country Link
UA (1) UA28288A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2610169C2 (en) * 2014-09-11 2017-02-08 Общество С Ограниченной Ответственностью "Валентек" Derivatives of 7-fluoro-8-chloro-5h-dibenzo [b, e] [1, 4] diazepine and their application

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2610169C2 (en) * 2014-09-11 2017-02-08 Общество С Ограниченной Ответственностью "Валентек" Derivatives of 7-fluoro-8-chloro-5h-dibenzo [b, e] [1, 4] diazepine and their application

Similar Documents

Publication Publication Date Title
DE10199020I2 (en) Galanthamine or its analogues for the treatment of Alzheimer's disease.
PH23867A (en) Method of treating parkinson's disease using indolone derivatives
MY108496A (en) Hypoglycemic thiazolidine diones.
HUT77380A (en) Use of a pharmaceutical combination for the treatment of multiple sclerosis (ms) and other demyelinating conditions
AU5287090A (en) Method and composition for treatment of periodontal disease
MX9704030A (en) 2-heterocyclyloxy and thiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof.
SI0785948T1 (en) Analogs of keratinocyte growth factor
UA41355C2 (en) Agent for treating neuro-aids
EP0793660A4 (en) 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
DE69424777D1 (en) 3,4-DIARYLCHROMANE FOR TREATING DERMATITIS
DE59605959D1 (en) Use of immunoglobulin preparations for the manufacture of a medicament for oral administration for the treatment and prophylaxis of chronic pain conditions
MX9704034A (en) Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof.
MD960168A (en) Method for treatment of viral infections and compounds therefor
IL115944A0 (en) A composition for the treatment of hiv-1 infection containing a heterocyclyl carb(ox/thio) anilide derivative
UA28288A (en) Method for treatment of schizophrenia
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
HU9200385D0 (en) Megacariocitopoietic factor
UA29461C2 (en) An agent for treatment of amyloidosis, a method for treatment of amyloidosis
HUP0004647A2 (en) Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
ZA885625B (en) Therapeutic agents containing enantiomers of propafenone
EP0353910A3 (en) Human interferon-gamma, process for preparing said human interferon-gamma, and its use
JO1493B1 (en) Pharmaceutical compositions for the treatment of high blood pressure
IL103499A0 (en) Pharmaceutical compositions for treating anxiety in benzodiazepine withdrawn patients
UA41376C2 (en) PHARMACEUTICAL COMPOSITION FOR TREATING ANDROGENIC ALOPECIA USING INHIBITOR OF 5<font face="Symbol">a</font>-REDUCTASE
HU908053D0 (en) Process for the production of medical preparations for the oral treatment of dopamine-deficiency